[1]
R. D. Ambròs, J. C. O. Morera, M. L. Iglesias-Lepine, D. P. Vidal, J. A. M. Ortiz, and J. L. Arias, “Efficacy and safety of intranasal haloperidol in an acute Psychiatry Unit: a pilot study on schizophrenic patients with mild-modedate agitation”, Actas Esp Psiquiatr, vol. 49, no. 5, pp. 205–209, Sep. 2021.